Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
Immune checkpoint inhibitor (ICI) therapy targeting anti-programmed cell death-1 (anti-PD-
1) or its ligand (anti-PD-L1) is the backbone of numerous combination regimens aimed at …
1) or its ligand (anti-PD-L1) is the backbone of numerous combination regimens aimed at …
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …
disease and affects nearly a quarter of the global population. The objective of this work was …
Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: a systematic review with meta-analysis
T Si, Z Huang, SE Khorsandi, Y Ma… - … in Bioengineering and …, 2022 - frontiersin.org
Background: Interest has revived in the use of hepatic arterial infusion chemotherapy (HAIC)
for intermediate-advanced hepatocellular carcinoma (HCC) while transarterial …
for intermediate-advanced hepatocellular carcinoma (HCC) while transarterial …
Outcome of no-touch radiofrequency ablation for small hepatocellular carcinoma: a multicenter clinical trial
DH Lee, MW Lee, PN Kim, YJ Lee, HS Park, JM Lee - Radiology, 2021 - pubs.rsna.org
Background Recently introduced no-touch radiofrequency ablation (RFA) of hepatocellular
carcinoma (HCC) has the potential to improve local tumor control. Purpose To evaluate …
carcinoma (HCC) has the potential to improve local tumor control. Purpose To evaluate …
Serum exosomal microRNA, miR-10b-5p, as a potential diagnostic biomarker for early-stage hepatocellular carcinoma
HJ Cho, JW Eun, GO Baek, CW Seo, HR Ahn… - Journal of Clinical …, 2020 - mdpi.com
Exosomal microRNAs (exo-miRs) have been promising cancer biomarkers. MiRs in
hepatocellular carcinoma (HCC) cell-derived exosomes (HEX) were analyzed to identify …
hepatocellular carcinoma (HCC) cell-derived exosomes (HEX) were analyzed to identify …
Laparoscopic liver resection versus percutaneous radiofrequency ablation for small single nodular hepatocellular carcinoma: comparison of treatment outcomes
DH Lee, JW Kim, JM Lee, JM Kim, MW Lee, H Rhim… - Liver cancer, 2021 - karger.com
Background: Treatment outcomes of laparoscopic liver resection (LLR) and percutaneous
radiofrequency ablation (p-RFA) for small single hepatocellular carcinomas (HCCs) have …
radiofrequency ablation (p-RFA) for small single hepatocellular carcinomas (HCCs) have …
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
Cancer cachexia affects quality of life, response to chemotherapy, and survival in many
advanced cancer patients. The aim of this study was to evaluate the prognostic value of …
advanced cancer patients. The aim of this study was to evaluate the prognostic value of …
Noncontrast MRI for hepatocellular carcinoma detection: a systematic review and meta-analysis–a potential surveillance tool?
Background and aims This meta-analysis investigates the diagnostic performance of non-
contrast magnetic resonance imaging (MRI) for the detection of hepatocellular carcinoma …
contrast magnetic resonance imaging (MRI) for the detection of hepatocellular carcinoma …
Paradigm shift in the treatment options of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is prevalent worldwide with suboptimal therapeutic
outcomes. The advancement of therapeutic options and the development of new systemic …
outcomes. The advancement of therapeutic options and the development of new systemic …
Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab
Background We investigated the combined effects of sarcopenia and inflammation on
outcomes in patients with HCC treated with nivolumab. Materials and Methods We reviewed …
outcomes in patients with HCC treated with nivolumab. Materials and Methods We reviewed …